CD274 and interstitial lung disease: In this study, we investigated the factors that may lead to the suspicion of ICI-ILD in patients receiving anti-PD-1/PD-L1 antibody, and showed that the new onset or worsening of subjective symptoms tended to, but not significantly, increase the risk of all grades of ICI-ILD.